Custom Built AI Research Environment Enables Faster Discovery and Reduced Costs Across Life Sciences and Medical Research
Briya, the health technology company redefining medical research, today announced the launch of Briya AIRE™, the world's first clinical-grade AI research assistant built to accelerate biomedical and clinical decision making. Designed to “think” in the language of medicine, clinical research and epidemiology, AIRE turns months of manual data analysis into actionable insights in minutes – enabling faster, cost-effective discovery across biopharma and academic research sectors.
“Incorporating Briya AIRE into research and clinical practice has the potential to revolutionize medical care,” said Robert Brown, MD, MPH,Vincent Astor Distinguished Professor of Medicine, Chief, Division of Gastroenterology and Hepatology at Weill Cornell Medicine. “Using AI to collate patient data and clinical evidence will allow physicians to make better decisions in a more efficient and timely manner while reducing administrative burden so they can spend more time interacting with and thinking about their patients.”
AIRE Insights Change Research and Treatment PrioritiesUnlike traditional AI tools that curate and synthesize data, Briya AIRE acts as a virtual epidemiologist and data analyst, helping researchers ask better questions and generate answers faster. It is built to design patient cohorts, test hypotheses, refine study criteria, and identify data patterns otherwise missed. By guiding researchers through these critical steps, Briya AIRE helps optimize study design and accelerate discoveries that can impact drug development and patient care.
Briya AIRE is being used by global academic medical centers, biopharma organizations and research institutions across a range of disciplines and therapeutic indications. Its advanced natural language processing and analytical capabilities have already demonstrated potential to facilitate earlier diagnosis, enabling timely interventions for at-risk patients.
“Using the advanced NLP capabilities, we can now accurately identify patients with metabolic dysfunction-associated steatohepatitis (MASH) at significant risk of progressing to severe liver damage or cirrhosis, directly from unstructured clinical data across the healthcare ecosystem,” said Gadi Lalazar, MD, Head of the Liver Unit, Shaare Zedek Medical Center, formerly affiliated with New York Presbyterian and Cornell. “This ability to automatically analyze imaging reports opens the door to earlier interventions for these high-risk patients, and spells promise for its use in a wide range of indications.”
Built to Accelerate Life-Sustaining and Saving Research”Life-saving research should never be delayed because researchers and physicians are expected to become program coders,” said David Lazerson, Co-founder and CEO of Briya. “Unlike general-purpose AI tools, Briya AIRE has been built specifically for clinical and biomedical researchers to ask questions in plain language, instantly translated into epidemiologically valid and scientifically precise requests. The outcome is an accelerated research journey.”
AI Made Simple for Science
— Researchers can ask questions in everyday language, which AIRE translates into precise medical and research terms, removing the need for coding expertise
— AIRE interfaces with existing clinical or hospital records, research databases and free-text doctors' notes, pulling all information into one view
— Automatic suggestions are grounded in peer-reviewed science, drawing from published medical studies and proven research methods, eliminating repetitive data preparation
— AIREis built on the Briya secure infrastructure and meets U.S. and European privacy standards, ensuring patient data remains protected
Briya AIRE is available at aire.briya.cloudor via the Briya website.
About BriyaBriya is a healthcare technology company dedicated to supporting vital medical and biopharma research and innovation with AI and data. Briya AIRE™, the first AI research engine built specifically for clinical and biomedical research, serves as an AI assistant across academia and the pharmaceutical industry. It can collect and analyze complex clinical data, generating insights that can be used to design cohorts, validate endpoints and meet key development milestones. With full anonymization and a federated data approach, Briya accelerates the path to discoveries while maintaining the highest standards of security, compliance, and trust.
For more information, follow us on LinkedInand X, or visit https://briya.com/.
Media Contact:FINN Partners for BriyaDanny Sudwartsdanny.sudwarts@finnpartners.com
https://c212.net/c/img/favicon.png?sn=LN38570&sd=2025-07-29
View original content:https://www.prnewswire.com/news-releases/briya-unveils-briya-aire-first-clinical-grade-ai-platform-to-accelerate-medical-and-epidemiological-research-302515940.html
SOURCE Briya
https://rt.newswire.ca/rt.gif?NewsItemId=LN38570&Transmission_Id=202507290830PR_NEWS_USPR_____LN38570&DateId=20250729